M
Mohammad Hassan Murad
Researcher at Mayo Clinic
Publications - 438
Citations - 43768
Mohammad Hassan Murad is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Meta-analysis & Randomized controlled trial. The author has an hindex of 90, co-authored 433 publications receiving 33176 citations. Previous affiliations of Mohammad Hassan Murad include King Saud bin Abdulaziz University for Health Sciences & University of Rochester.
Papers
More filters
Journal ArticleDOI
Are there sex differences following treatment of left ventricular outflow tract obstruction in adults with hypertrophic cardiomyopathy
Anwar A. Chahal,Anwar A. Chahal,Anwar A. Chahal,Rabe E. Alhurani,Essa A. Mohamed,Virend K. Somers,Virginia M. Miller,Mohammad Hassan Murad,Ahmed T. Ahmed +8 more
TL;DR: An a priori protocol to determine if there were sex differences in selection of treatment and outcomes for HOCM was created for a systematic review to predefine population criteria, description of interventions, and comparisons of the outcomes of interest of three treatments.
Journal ArticleDOI
Hyperlipidaemia and mortality among patients hospitalised with pneumonia: retrospective cohort and propensity score matched study.
TL;DR: In this paper, the potential association of hyperlipidaemia (HLP) versus no HLP with all-cause mortality among patients hospitalised for pneumonia was investigated. But, the authors did not identify the patients with concurrent HLP and propensity score matched in a 1:1 ratio to 1879 patients without HLP to minimize the imbalance from measured covariates.
Journal ArticleDOI
Tu1871 – The Association Between Antibiotics Exposure During the Peripartum Period and the Risk of Developing Autoimmune and Autistic Spectrum Disorders
Journal ArticleDOI
Aspirin dosage for the prevention of graft occlusion in people undergoing coronary surgery: A systematic review and meta-analysis.
Fares Alahdab,Ruba Zuhri Yafi,Abdelkader Chaar,Ali Alrstom,Muayad A Alzuabi,Omar Alhalabi,Somar Hasan,Mahmoud Mallak,Mohamad Luay Jazayerli,Qusay Haydour,Mohamad Alkhouli,Wedad Alfarkh,Mohammad Hassan Murad +12 more
TL;DR: High-dose aspirin was superior to low- dose aspirin in suppressing platelet function, a surrogate outcome, and no clinical trials addressing any of the clinical outcomes of interest were found.